Asiatic Laboratories Limited (DSE:ASIATICLAB)

Asiatic Laboratories Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	1,473	1,451	1,326
Revenue Growth (YoY)	1.48%	9.42%	-
Cost of Revenue	835.39	827.88	756.23
Gross Profit	637.39	623.38	570.13
Selling, General & Admin	221.76	207.87	172.98
Operating Expenses	221.76	207.87	172.98
Operating Income	415.63	415.51	397.15
Interest Expense	-41.02	-43.92	-51.38
Currency Exchange Gain (Loss)	1.41	0.27	0.16
Other Non Operating Income (Expenses)	-0.26	-0.38	-0.34
Pretax Income	375.76	371.48	345.59
Income Tax Expense	107.2	50.95	103.14
Net Income	268.56	320.52	242.45
Net Income to Common	268.56	320.52	242.45
Net Income Growth	-16.21%	32.20%	-
Shares Outstanding (Basic)	88	88	88
Shares Outstanding (Diluted)	88	88	88
EPS (Basic)	3.06	3.65	2.76
EPS (Diluted)	3.06	3.65	2.76
EPS Growth	-16.21%	32.20%	-
Free Cash Flow	-	56.91	159.27
Free Cash Flow Per Share	-	0.65	1.81
Gross Margin	43.28%	42.95%	42.98%
Operating Margin	28.22%	28.63%	29.94%
Profit Margin	18.23%	22.09%	18.28%
Free Cash Flow Margin	-	3.92%	12.01%
EBITDA	504.82	504.7	475.9
EBITDA Margin	34.28%	34.78%	35.88%
D&A For EBITDA	89.19	89.19	78.75
EBIT	415.63	415.51	397.15
EBIT Margin	28.22%	28.63%	29.94%
Effective Tax Rate	28.53%	13.72%	29.84%
Advertising Expenses	7.36	6.11	5.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.